Invention Grant
- Patent Title: 2′-substituted carba-nucleoside analogs for antiviral treatment
-
Application No.: US16016369Application Date: 2018-06-22
-
Publication No.: US10941177B2Publication Date: 2021-03-09
- Inventor: Michael O' Neil Hanrahan Clarke
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07H19/23
- IPC: C07H19/23 ; A61K31/706 ; A61K45/06 ; C07H19/12
Abstract:
Provided are compounds of Formula I, as well as pharmaceutical compositions containing compounds of Formula I and methods for treating Orthomyxoviridae virus infections by administering these compounds. The compounds, compositions, and methods provided are particularly useful for the treatment of Human Influenza virus infections.
Public/Granted literature
- US20190016749A1 2'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT Public/Granted day:2019-01-17
Information query
IPC分类:
